What is the address of DEHAENE SEPPE, ANESTHESIST?

The registered office of DEHAENE SEPPE, ANESTHESIST is located at Stationsstraat 44, 8930 Menen.

Is DEHAENE SEPPE, ANESTHESIST still active?

Yes. According to the CBE (31 October 2026) DEHAENE SEPPE, ANESTHESIST is active, legal situation “Normale toestand”, started on 14 October 2016.

Is DEHAENE SEPPE, ANESTHESIST registered on Peppol?

Yes, DEHAENE SEPPE, ANESTHESIST is registered on the Peppol network with ID 0208:0664645582.

What is the enterprise number of DEHAENE SEPPE, ANESTHESIST?

The enterprise number of DEHAENE SEPPE, ANESTHESIST is BE0664645582.

When was DEHAENE SEPPE, ANESTHESIST founded?

DEHAENE SEPPE, ANESTHESIST was founded on 14 October 2016.

Who are the directors of DEHAENE SEPPE, ANESTHESIST?

According to the 2025 annual accounts, the directors of DEHAENE SEPPE, ANESTHESIST are: Seppe Dehaene.

Is DEHAENE SEPPE, ANESTHESIST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 October 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DEHAENE SEPPE, ANESTHESIST make in 2025?

DEHAENE SEPPE, ANESTHESIST posted a profit after taxes of € 348,991 in financial year 2025.

What is the revenue of DEHAENE SEPPE, ANESTHESIST?

As a small company, DEHAENE SEPPE, ANESTHESIST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 462,856.

DEHAENE SEPPE, ANESTHESIST (Private Limited) - Menen

Dossier DEHAENE SEPPE, ANESTHESIST, printed on 31 October 2026 from databakkes.be/en/0664645582/dehaene-seppe-anesthesist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DEHAENE SEPPE, ANESTHESIST from Menen, company number BE0664645582, closed financial year 2025 with a result of € 348,991 after tax. For that financial year DEHAENE SEPPE, ANESTHESIST recorded a gross margin of € 462,856 and equity of € 373,135. Compared with financial year 2024, the result moved from € 252,414 to € 348,991. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What it is worth Healthy

€ 373,135

▼ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 348,991

▲ 38% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 208,901

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 500,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,015

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,158

▲ 205% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 317,420 Gross margin 2022: € 317,420 First fiscal year in the series	€ 303,743 Gross margin 2023: € 303,743 ▼ 4% vs 2022 (€ 317,420) Unfavourable step	€ 327,624 Gross margin 2024: € 327,624 ▲ 8% vs 2023 (€ 303,743) Favourable step	€ 462,856 Gross margin 2025: € 462,856 ▲ 41% vs 2024 (€ 327,624) Favourable step	▲ 41%
Profit after taxes	€ 241,712 Profit after taxes 2022: € 241,712 First fiscal year in the series	€ 230,934 Profit after taxes 2023: € 230,934 ▼ 4% vs 2022 (€ 241,712) Unfavourable step	€ 252,414 Profit after taxes 2024: € 252,414 ▲ 9% vs 2023 (€ 230,934) Favourable step	€ 348,991 Profit after taxes 2025: € 348,991 ▲ 38% vs 2024 (€ 252,414) Favourable step	▲ 38%
Equity	€ 590,796 Equity 2022: € 590,796 First fiscal year in the series	€ 521,730 Equity 2023: € 521,730 ▼ 12% vs 2022 (€ 590,796) Unfavourable step	€ 524,144 Equity 2024: € 524,144 Unchanged (€ 521,730) Favourable step	€ 373,135 Equity 2025: € 373,135 ▼ 29% vs 2024 (€ 524,144) Unfavourable step	▼ 29%
Total debts	€ 21,077 Total debts 2022: € 21,077 First fiscal year in the series	€ 27,560 Total debts 2023: € 27,560 ▲ 31% vs 2022 (€ 21,077) Unfavourable step	€ 274,972 Total debts 2024: € 274,972 ▲ € 247,413 vs 2023 (€ 27,560) Unfavourable step	€ 39,598 Total debts 2025: € 39,598 ▼ 86% vs 2024 (€ 274,972) Favourable step	▼ 86%
Cash	€ 487,371 Cash 2022: € 487,371 First fiscal year in the series	€ 427,480 Cash 2023: € 427,480 ▼ 12% vs 2022 (€ 487,371) Unfavourable step	€ 229,118 Cash 2024: € 229,118 ▼ 46% vs 2023 (€ 427,480) Unfavourable step	€ 208,901 Cash 2025: € 208,901 ▼ 9% vs 2024 (€ 229,118) Unfavourable step	▼ 9%
Retained profit	€ 572,196 Retained profit 2022: € 572,196 First fiscal year in the series	€ 503,130 Retained profit 2023: € 503,130 ▼ 12% vs 2022 (€ 572,196) Unfavourable step	€ 505,544 Retained profit 2024: € 505,544 Unchanged (€ 503,130) Favourable step	€ 354,535 Retained profit 2025: € 354,535 ▼ 30% vs 2024 (€ 505,544) Unfavourable step	▼ 30%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 300,000 Dividend 2023: € 300,000 ▲ € 299,200 vs 2022 (€ 800) Unchanged	€ 250,000 Dividend 2024: € 250,000 ▼ 17% vs 2023 (€ 300,000) Unchanged	€ 500,000 Dividend 2025: € 500,000 ▲ 100% vs 2024 (€ 250,000) Unchanged	▲ 100%
Balance sheet total	€ 611,873 Balance sheet total 2022: € 611,873 First fiscal year in the series	€ 549,290 Balance sheet total 2023: € 549,290 ▼ 10% vs 2022 (€ 611,873) Unchanged	€ 799,116 Balance sheet total 2024: € 799,116 ▲ 45% vs 2023 (€ 549,290) Unchanged	€ 412,733 Balance sheet total 2025: € 412,733 ▼ 48% vs 2024 (€ 799,116) Unchanged	▼ 48%

Key figures of DEHAENE SEPPE, ANESTHESIST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DEHAENE SEPPE, ANESTHESIST?

What happened at DEHAENE SEPPE, ANESTHESIST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 16, 2026 New annual accounts for financial year 2025: profit of € 348,991 (▲ 38% vs 2024). Source: NBB ↗
Oct 14, 2016 New establishment in Menen. KBO
Oct 14, 2016 Start of the company according to the CBE. KBO
2016 Seppe Dehaene became a director. NBB

In short

From € 241,712 profit in 2022 to € 348,991 profit in 2025.

Paid € 334,121 in corporate taxes since 2022.

Best year ever: 2025, with € 348,991 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Seppe Dehaene

DEHAENE SEPPE, ANESTHESIST

Behind DEHAENE SEPPE, ANESTHESIST is Seppe Dehaene.

Directors

According to the 2025 annual accounts

Seppe Dehaene

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 44

8930 Menen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0664.645.582
VAT number: BE 0664.645.582
Registered office: Stationsstraat 44, 8930 Menen
Names & denominations: DEHAENE SEPPE, ANESTHESIST
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 October 2016
Peppol: Active · Active since 3 Nov 2025

View on CBE Public ↗ Annual accounts (NBB) ↗